Skip to content
Recall Observatory FDA recall evidence

Drug product

Valsartan Tablets, USP 160 mg, 90-count bottle (NDC 0591-2169-19), 1000-count bottle (NDC 0591-2169-10), Rx Only, Rx Only, Manufactured by: Arrow Pharma (Malta) Ltd. India, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054

D-0988-2018

July 16, 2018

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 80538
Status
Ongoing
Classification
Class II
Quantity
15,347 90-count bottles, 8,378 1000-count bottles
Official record key
drug-enforcement:D-0988-2018

Official wording

Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Code information: NDC 0591-2169-19 Lot Numbers: 1177880A, 1220831A, 1263941A NDC 0591-2169-10 1175922M, 1220826M, 1236294M, 1240427M, 1270616A

Distribution pattern: Product was distributed throughout the United States, including Hawaii and Puerto Rico

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations